Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | ANNUAL REPORT | ea0275233-10k_green.htm iXBRL | 10-K | 1317579 |
| 2 | FORM OF EMPLOYMENT AGREEMENT BETWEEN THE COMPANY AND PETER MORIARTY (COO) EFFECT | ea027523301ex10-19.htm | EX-10.19 | 12036 |
| 3 | FORM OF EMPLOYMENT AGREEMENT BETWEEN THE COMPANY AND JEFFREY LEBLANC (CFO) EFFEC | ea027523301ex10-20.htm | EX-10.20 | 12037 |
| 4 | SECURITIES PURCHASE AGREEMENT BETWEEN THE COMPANY AND THE INVESTOR SIGNATORY THE | ea027523301ex10-23.htm | EX-10.23 | 276072 |
| 5 | SENIOR CONVERTIBLE NOTE BETWEEN THE COMPANY AND THE HOLDER, ISSUED JANUARY 23, 2 | ea027523301ex10-24.htm | EX-10.24 | 251126 |
| 6 | SUBSIDIARIES OF THE REGISTRANT | ea027523301ex21-1.htm | EX-21.1 | 1060 |
| 7 | CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (BCRG) | ea027523301ex23-1.htm | EX-23.1 | 2336 |
| 8 | CERTIFICATION | ea027523301ex31-1.htm | EX-31.1 | 8639 |
| 9 | CERTIFICATION | ea027523301ex31-2.htm | EX-31.2 | 8670 |
| 10 | CERTIFICATION | ea027523301ex32-1.htm | EX-32.1 | 4229 |
| 11 | CERTIFICATION | ea027523301ex32-2.htm | EX-32.2 | 4359 |
| 12 | GRAPHIC | ea027523301_img1.jpg | GRAPHIC | 17463 |
| 13 | GRAPHIC | ea027523301_ex10-19img1.jpg | GRAPHIC | 1003377 |
| 14 | GRAPHIC | ea027523301_ex10-19img2.jpg | GRAPHIC | 999054 |
| 15 | GRAPHIC | ea027523301_ex10-19img3.jpg | GRAPHIC | 1194264 |
| 16 | GRAPHIC | ea027523301_ex10-19img4.jpg | GRAPHIC | 1239914 |
| 17 | GRAPHIC | ea027523301_ex10-19img5.jpg | GRAPHIC | 1104560 |
| 18 | GRAPHIC | ea027523301_ex10-19img6.jpg | GRAPHIC | 1016025 |
| 19 | GRAPHIC | ea027523301_ex10-19img7.jpg | GRAPHIC | 1024371 |
| 20 | GRAPHIC | ea027523301_ex10-19img8.jpg | GRAPHIC | 1171935 |
| 21 | GRAPHIC | ea027523301_ex10-19img9.jpg | GRAPHIC | 1194389 |
| 22 | GRAPHIC | ea027523301_ex10-19img10.jpg | GRAPHIC | 1091216 |
| 23 | GRAPHIC | ea027523301_ex10-19img11.jpg | GRAPHIC | 1202361 |
| 24 | GRAPHIC | ea027523301_ex10-19img12.jpg | GRAPHIC | 1049834 |
| 25 | GRAPHIC | ea027523301_ex10-19img13.jpg | GRAPHIC | 1013529 |
| 26 | GRAPHIC | ea027523301_ex10-19img14.jpg | GRAPHIC | 725449 |
| 27 | GRAPHIC | ea027523301_ex10-19img15.jpg | GRAPHIC | 228635 |
| 28 | GRAPHIC | ea027523301_ex10-20img1.jpg | GRAPHIC | 1002550 |
| 29 | GRAPHIC | ea027523301_ex10-20img2.jpg | GRAPHIC | 1012446 |
| 30 | GRAPHIC | ea027523301_ex10-20img3.jpg | GRAPHIC | 1265405 |
| 31 | GRAPHIC | ea027523301_ex10-20img4.jpg | GRAPHIC | 1227571 |
| 32 | GRAPHIC | ea027523301_ex10-20img5.jpg | GRAPHIC | 1168294 |
| 33 | GRAPHIC | ea027523301_ex10-20img6.jpg | GRAPHIC | 1006646 |
| 34 | GRAPHIC | ea027523301_ex10-20img7.jpg | GRAPHIC | 1025771 |
| 35 | GRAPHIC | ea027523301_ex10-20img8.jpg | GRAPHIC | 1197366 |
| 36 | GRAPHIC | ea027523301_ex10-20img9.jpg | GRAPHIC | 1160978 |
| 37 | GRAPHIC | ea027523301_ex10-20img10.jpg | GRAPHIC | 1109024 |
| 38 | GRAPHIC | ea027523301_ex10-20img11.jpg | GRAPHIC | 1214094 |
| 39 | GRAPHIC | ea027523301_ex10-20img12.jpg | GRAPHIC | 977982 |
| 40 | GRAPHIC | ea027523301_ex10-20img13.jpg | GRAPHIC | 1088460 |
| 41 | GRAPHIC | ea027523301_ex10-20img14.jpg | GRAPHIC | 708141 |
| 42 | GRAPHIC | ea027523301_ex10-20img15.jpg | GRAPHIC | 157196 |
| Complete submission text file | 0001213900-26-038629.txt | 49664026 |
Data Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 43 | XBRL SCHEMA FILE | klto-20251231.xsd | EX-101.SCH | 63033 |
| 44 | XBRL CALCULATION FILE | klto-20251231_cal.xml | EX-101.CAL | 43796 |
| 45 | XBRL DEFINITION FILE | klto-20251231_def.xml | EX-101.DEF | 338744 |
| 46 | XBRL LABEL FILE | klto-20251231_lab.xml | EX-101.LAB | 573580 |
| 47 | XBRL PRESENTATION FILE | klto-20251231_pre.xml | EX-101.PRE | 348625 |
| 110 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0275233-10k_green_htm.xml | XML | 578194 |
EIN.: 862727441 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41340 | Film No.: 26829350
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)